Screen of the glycolytic metabolites affected by DIO3OS and PTBP1 and further verification of the splicing events in glycolytic enzymes identified LDHA as a key downstream target of DIO3OS and PTBP1 in AI-resistant breast cancer cells. Here, LDHA is linked to breast carcinoma.